A new tactic for eczema?March 06, 2018
Eczema affects about 17 percent of children in developed countries and is often the gateway to food allergy and asthma, initiating an "atopic march" toward broader allergic sensitization. There are treatments - steroid creams and a recently approved biologic - but they are expensive or have side effects. A new study in Science Immunology suggests a different approach to eczema, one that stimulates a natural brake on the allergic attack.
The skin inflammation of eczema is known to be driven by "type 2" immune responses. These are led by activated T helper 2 (TH2) cells and type 2 innate lymphoid cells (ILC2s), together known as effector cells. Another group of T cells, known as regulatory T cells or Tregs, are known to temper type 2 responses, thereby suppressing the allergic response.
Yet, if you examine an eczema lesion, the numbers of Tregs are unchanged. Interestingly, Tregs comprise only about 5 percent of the body's T cells, but up to 50 percent of T cells in the skin.
"Our question was, is there something special about the Tregs that reside in the skin?" says Raif Geha, MD, chief of the Division of Immunology at Boston Children's Hospital and the senior author of the study.
Geha led an investigation using two separate mouse models of eczema, each recreating a separate pathway leading to allergic skin inflammation. The team purified Tregs from the animals' skin and blood and compared the genes they express.
Several genes were especially likely to be turned on in the skin Tregs. One encodes retinoid-related orphan receptor alpha (RORα), a transcription factor that itself regulates multiple other genes.
"We then used a genetic trick to remove RORα only from Tregs," says Geha. "Without RORα, allergic inflammation went crazy in both our mouse models."
The team saw a three-fold increase in the influx of inflammatory cells, and ILC2s and TH2 cells were at the center of the action.
Restraining allergic skin inflammation
Why did the Tregs stop working when RORα was removed? Geha and colleagues discovered that the cells made less of a receptor for a cytokine called TNF ligand-related molecule 1, or TL1A. TL1A is released by skin cells known as keratinocytes, and activates not only Tregs but also ILC2 and TH2 effector cells.
"The two kinds of immune cells are competing for TL1A," Geha explains. "If Tregs don't have this receptor, they can't 'see' TL1A. Not only are they not activated, but more TL1A is available to activate the effector cells. So you have a double whammy."
Testing human samples, the team documented higher expression of RORα in skin Tregs compared with those in blood, similar to mice.
Geha now wants to see if RORα is expressed less in human eczema and whether it's important in the atopic march. If so, he sees several possible treatment approaches.
One is to boost RORα's level or activity with compounds that act as RORα agonists, perhaps given in a topical cream. Geha's lab also plans to look for factors in the skin that drive RORα activity, which could present other targets for intervention. Finally, the study showed that RORα regulates the expression of several genes important for Treg cell migration and function; those pathways could be potential targets too.
Boston Children's Hospital
Related Immune Cells Articles:
A genetic variant that is particularly prevalent in people of African ancestry confers protection against malaria.
Dendritic cells are gatekeepers of Immunity. Up to now dendritic cell subtypes were thought to develop from one common progenitor.
Researchers from the University of Zurich have individually analyzed millions of immune cells in tumor samples from patients with renal cell carcinoma.
A high-fat diet and obesity turn 'hero' virus-fighting liver immune cells 'rogue,' leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.
Immune cells which are reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between the University of Manchester, Lund University and the University of Salford.
Michigan State University researchers are the first to uncover reasons why a specific type of immune cell acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Opioids are the most powerful painkillers. Researchers at the Charité -- Universitätsmedizin Berlin have now found that the analgesic effects of opioids are not exclusively mediated by opioid receptors in the brain, but can also be mediated via the activation of receptors in immune cells.
Scientists at the Immunology Frontier Research Center (IFReC) at Osaka University, Japan, report a new group of monocytes they call SatM.
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Related Immune Cells Reading:
Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives
by Neil H Riordan (Author)
Stem cells are the repair cells of your body. When there aren’t enough of them, or they aren’t working properly, chronic diseases can manifest and persist. From industry leaders, sport stars, and Hollywood icons to thousands of everyday, ordinary people, stem cell therapy has helped when standard medicine failed. Many of them had lost hope. These are their stories.
Neil H Riordan, author of MSC: Clinical Evidence Leading Medicine’s Next Frontier, the definitive textbook on clinical stem cell therapy, brings you an easy-to-read book about how and why stem cells work,... View Details
Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation, Second Edition: Models in Discovery and Translation
by Gerard Socie (Editor), Robert Zeiser (Editor), Bruce R. Blazar (Editor)
Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation, Second Edition: Models in Discovery and Translation provides clinical and scientific researchers with a deep understanding of the current research in this field and its implications for translational practice. By providing an overview of the immune biology of HSCT, an explanation of immune rejection, and detail on antigens and their role in HSCT success, this book embraces biologists and clinicians who need a broad view of the deeply complex processes involved. It then moves on to discuss the immunobiology... View Details
Guide to Signal Pathways in Immune Cells
by E. Nigel Wardle (Author)
To read current biomedical science, one has to have a working knowledge of how important effector molecules cause transduction of their signal within cells, altering the control of genes. This work aims to provide that basic knowledge for medical readers. Students of immunology or cell biology will note its relevance. One will learn how platelets, macrophages, neutrophils, T and B lymphocytes and natural killer cells perform their functions and how skin, breast, prostate and colon cancers emerge. The associated diagrams and tables are used to obviate extensive text. Appropriate references to... View Details
Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)
The revolutionary, New York Times bestselling guide to the powerful lifestyle changes that fight and prevent cancer—an integrative approach based on the latest scientific research
“A common-sense blueprint for healthy living.” —Chicago Tribune
“Resonating with cancer support communities and recommended nationwide.” —Los Angeles Times
“Life affirming . . . filled with practical advice.” —The Seattle Times
David Servan-Schreiber was a rising... View Details
A Stem Cell Transplant MS Recovery Story: Beating Multiple Sclerosis with Humor,
by Sandi Selvi (Author)
This is a hysterical book about a woman who found out she had Multiple Sclerosis, began declining rapidly and decided to take charge of her own health. It is her funny take on how she got M.S., why she got M.S., and what she did about it. The medications she was given by her doctors were no longer working so in March of 2000 she volunteered for a stem cell transplant at Scripps in San Diego, CA. During this experiment she almost died. So she listened to comedy tapes. It was the laughter that kept her alive. So now that she has been given a second chance at life, she decided to become a... View Details
Polymyalgia Rheumatica and Giant Cell Arteritis: a survival guide. 2nd edition.
by Kate Gilbert PhD (Author)
Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA) are linked rheumatic inflammatory illnesses that affect older people – generally, people over 50. They are chronic autoimmune conditions that cause untold misery, pain and debilitation. More acutely, undiagnosed GCA can lead to blindness, which is irreversible. In the United Kingdom each year, there are an estimated 40,000 new cases of PMR and 10,000 new cases of GCA, with a significant degree of overlap, many people having both conditions together. Many people, when they first get their diagnosis, have never heard of PMR or GCA... View Details
Your Body's Heroes and Villains: Microexplorers : Learning Aobut Immune Cells : The Tiny Defenders That Safeguard Our Lives Against Nasty Bacteria and Viruses (Microexplorers Series)
by Patrick A. Baeuerle (Author), Norbert Landa (Author)
Looks at how viruses and bacteria can change and affect healthy cells, and how antibodies and white blood cells help fight their effects View Details
Antibodies that Cause Thyroid Diseases and Symptoms: Immune Cells causing Hypothyroidism & Hyperthyroidism
by James M. Lowrance (Author)
The majority of patients with both hypothyroidism (under-active thyroid) and hyperthyroidism (overactive thyroid) are experiencing autoimmune diseases that cause these conditions. When autoimmune thyroid disease results in hypothyroidism, the term for the disease is "Hashimoto's thyroiditis." When the autoimmune disease of the thyroid causes hyperthyroidism, it is called "Grave's Disease." Thyroid antibodies attack key proteins in the thyroid gland and in some cases, stimulate production of excessive amounts of hormone. These killer cells that are manufactured by the immune system become... View Details
Transcriptional Control of Lineage Differentiation in Immune Cells (Current Topics in Microbiology and Immunology)
by Wilfried Ellmeier (Editor), Ichiro Taniuchi (Editor)
Insights into the regulation of immune cell lineage differentiation and specification as well as into the control of lineage integrity, stability and plasticity are of fundamental importance to understanding innate and adaptive immune responses. In this volume, leading experts provide an up-to-date and comprehensive overview of recent advances in the transcriptional control mechanisms and transcription factor networks that regulate these processes in a variety of different immune cell lineages. The chapters cover the regulation of T versus B cell lineage choice, discuss early B cell... View Details
A Guide to Transfer Factors and Immune System Health: 2nd edition, Helping the body heal itself by strengthening cell-mediated immunity
by Aaron White PhD (Author)
In the second edition of this popular book, Dr. White takes readers on a tour of the human immune system, explores the nature of immune disorders from cancer to HIV and presents evidence that immune messengers called transfer factors can help the body beat a wide variety of diseases for which effective treatments are lacking. In language that is easy to follow, Dr. White explains how transfer factors help the body fight viruses (herpes, hepatitis C, HPV, HIV), mycobacteria (tuberculosis), cell-wall deficient bacteria (Lyme), cancers, autoimmune diseases and other conditions. Like vaccines but... View Details